Abstract
The obligate intracellular bacterium, Chlamydia pneumoniae, has been identified as a risk factor for several chronic inflammatory diseases in addition to respiratory tract infections. The dissemination of C. pneumoniae from respiratory tract to secondary sites of infection occurs via infected monocyte / macrophage line cells, in which C. pneumoniae can persist as an antibiotic-refractory phenotype. To allow more detailed studies on the epithelium-monocyte/macrophage transition of the infection, new in vitro bioassays are needed. To this end, a coculture system with human continuous cell lines was established. Respiratory epithelial HL cells were infected with C. pneumoniae and THP-1 monocytes were added into the cultures at 67 h post infection. After a 5 h coculture, THP-1 cells were collected with a biotinylated HLA antibody and streptavidin-coated magnetic beads and C. pneumoniae genome copy numbers in THP-1 determined by quantitative PCR. The assay was optimized for cell densities, incubation time, THP-1 separation technique and buffer composition, and its robustness was demonstrated by a Z' value of 0.6. The mitogen-activated protein kinase (MAPK) inhibitors: SP600125 (JNK inhibitor), SB203580 (p38 inhibitor) and FR180204 (ERK inhibitor) suppressed the transfer of C. pneumoniae from HL to THP-1 cells, making them suitable positive controls for the assay. Based on analysis of separate steps of the process, the MAPK inhibitors suppress the bacterial entry to THP-1 cells. The transfer of C. pneumoniae from epithelium to phagocytes represents a crucial step in the establishment of persistent infections by this pathogen, and the presented methods enables future studies to block this process by therapeutic means.
Highlights
Chlamydia pneumoniae is a gram-negative, obligate intracellular bacterium, whose primary site of infection is the respiratory tract (Kuo et al, 2015)
The epithelial human lung (HL) cells were infected with C. pneumoniae and at 67 h post infection, representing a late stage of the replication cycle of C. pneumoniae, uninfected THP-1 monocytes were added to the wells in a ratio of 1:1
In control samples collected from cultures with uninfected HL cells, minor nonspecific amplification yielded a in apparent genome copy numbers (GE) numbers of 13.4, more than 2200 times smaller than in infection samples (S/B = 2209)
Summary
Chlamydia pneumoniae is a gram-negative, obligate intracellular bacterium, whose primary site of infection is the respiratory tract (Kuo et al, 2015). It causes various acute illnesses such as pharyngitis, sinusitis and it is a cause of 10% of community acquired pneumonia (CAP) (Kuo et al, 1995). In addition to respiratory tract infections, C. pneumoniae has been identified as a risk factor for several chronic inflammatory diseases such as asthma (Smith-Norowitz et al, 1971; Webley and Hahn, 2017), atherosclerosis (Campbell and Kuo, 2004; Filardo et al, 2015) and Alzheimer's disease and neurovascular complications (Little et al., 2004; Balin PhD et al, 2017; Richard, 2018). C. pneumoniae DNA has been detected from post mortem Alzheimer's brain samples (Balin et al, 1998) and the infection has been found to induce amyloid plague
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have